Abstract:The tumor specific internalization of therapeutics drug is been a great importance for cancer therapy. Targeted macromolecular carrier has been used as drug cargos since it improve the cellular uptake of cytotoxic drug in the tumor, while preventing cellular uptake by healthy tissues. Because of favorable pharmokinetic profile, elastin like polypeptide (ELPs) has been used as macromolecular drug carrier for cancer therapy. Fusion with cell-penetrating peptides (CPPs) such as TAT, assist easy penetration and internalization of macromolecular drug conjugates into wide variety of tumor types. For therapeutic peptide to be more penetrable and more effective towards specific tumor tissue, here we have designed a chimeric polypeptide cargo, TAT-AP1-ELP containing TAT, IL-4 receptor (IL4R) targeting peptide AP-1and thermal sensitive elastin-like polypeptides (ELPs). Then it was successfully expressed and purified from E coli using inverse temperature cycling method. Cellular uptake and intracellular localization of TAT-AP1-ELP was monitored through flow cytometry and confocal microscopy. Flow cytometry analysis data shown that both TAT-AP1-ELP and TAT-ELP showed various extends of penetration ability to different cancer cells but not to normal cells. Further a greater cellular uptake was observed in IL4R highly expressing cancer cells when treated with TAT-AP1-ELP compared to TAT-ELP at 37°C in dose-dependent manner. Confocal imaging verified the better cellular accumulation of TAT-AP1-ELP than TAT-ELP in IL4R highly expressing cancer cells. Importantly, the FNR 675-labeled TAT-AP1-ELP polymer showed better tumor accumulation in MDA-MB 231 xenograft mouse model. Thus in this study we demonstrate the improved activity of CPP, fused with targeting modalities in order to enhance intra tumor accumulation of therapeutic peptides. Citation Format: Young-Jin Lee, Vijaya Sarangthem, Yun-Jae Kim, Kuen Hur, Byung-Heon Lee, Rang Woon Park. Evaluation of tumor targeting activity by elastin like polypeptide containing cell penetrating peptide and IL-4 receptor targeting peptide. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 4391. doi:10.1158/1538-7445.AM2015-4391

In Vivo Characterization Of Activatable Cell Penetrating Peptides For Targeting Protease Activity In Cancer

Tumor Imaging by Means of Proteolytic Activation of Cell-Penetrating Peptides

Systemic In Vivo Distribution Of Activatable Cell Penetrating Peptides Is Superior To That Of Cell Penetrating Peptides

Enhancing cellular uptake of activable cell-penetrating peptide-doxorubicin conjugate by enzymatic cleavage.

Tumor-Targeted Cell-Penetrating Peptides Reveal That Monomethyl Auristatin E Temporally Modulates the Tumor Immune Microenvironment

Acid-active Cell-Penetrating Peptides for in Vivo Tumor-Targeted Drug Delivery.

Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases.

Protease-Activable Cell-Penetrating Peptide–Protoporphyrin Conjugate for Targeted Photodynamic Therapy in Vivo

Application of activatable cell-penetrating peptide in the field of tumor therapy

Activable Cell-Penetrating Peptide Conjugated Prodrug for Tumor Targeted Drug Delivery

Activatable Cell Penetrating Peptide-Conjugated Nanoparticles with Enhanced Permeability for Site-Specific Targeting Delivery of Anticancer Drug

[The Application of Enzyme-Sensitive Activatable Cell-Penetrating Peptides to Targeted Delivery System].

Surgery With Molecular Fluorescence Imaging Using Activatable Cell-Penetrating Peptides Decreases Residual Cancer And Improves Survival

De-shielding of Activatable Cell-Penetrating Peptides: Recognizing and Releasing in Activation Process

Angiopep-2 and Activatable Cell Penetrating Peptide Dual Modified Nanoparticles for Enhanced Tumor Targeting and Penetrating.

[The Design and Enzymatic Hydrolysis of Activatable Cell-Penetrating Peptide].

Abstract 4391: Evaluation of tumor targeting activity by elastin like polypeptide containing cell penetrating peptide and IL-4 receptor targeting peptide

Cell-Penetrating Peptides: Applications in Tumor Diagnosis and Therapeutics

In Vivo Fluorescence Imaging of Atherosclerotic Plaques with Activatable Cell-Penetrating Peptides Targeting Thrombin Activity.

Tumor microenvironment-responsive cell-penetrating peptides: Design principle and precision delivery

Cell penetrating peptides improve tumor delivery of cargos through neuropilin-1-dependent extravasation